After 12 million measurements, new drug targets emerge
News and Announcements
The addition of 367 new pathology slides and 51 new pathology subjects for lung squamous cell carcinoma is now available on the TCIA CPTAC Pathology Portal. Also available is more imaging data is...
January 29, 2020 | Read More
The Office of Cancer Clinical Proteomics Research (OCCPR) cares what you think about the Clinical Proteomic Tumor Analysis Consortium (CPTAC) program and all its offerings! Working with Clarivate Analytics to conduct a survey, we wanted to determine the effect of the CPTAC program on the...
January 29, 2020 | Read More
Visualizing gene and protein expression from comprehensive genomics and proteomics (mass spectrometry generated) data is beneficial for researchers but often difficult to achieve. Researchers from the Mount Sinai PGDAC team within the CPTAC program have developed a new interactive data tool to...
January 28, 2020 | Read More
Using a using a single-needle biopsy and new technology for tumor diagnosis developed by Baylor College of Medicine and the Broad Institute of MIT and Harvard, researchers have been able to provide a more detailed and wider window into cancer biology, tumor type and the mechanisms of response...
January 27, 2020 | Read More
The Genomic Data Commons (GDC) data release 22 is now available and includes data from the CPTAC ...
January 21, 2020 | Read More
The Clinical Proteomic Tumor Analysis Consortium (CPTAC), sponsored by the National Cancer Institute’s (NCI) Office of Cancer Clinical Proteomics Research (OCCPR) and managed by The Frederick National Laboratory for Cancer Research (FNLCR), is a national effort to accelerate the understanding of...
January 10, 2020 | Read More
Glioblastoma Multiforme Discovery Study proteomic and phosphoproteomic data previously available only on thte CPTAC Data Portal is now available on the...
January 3, 2020 | Read More
TCIA has released its quarterly update for CPTAC radiology data with 44 new radiology cases! These cases span cutaneous melanoma, glioblastoma multiforme, head & neck squamous cell carcinoma, lung squamous cell carcinoma, lung adenocarcinoma, pancreatic ductal adenocarcinoma and sarcoma...
January 2, 2020 | Read More
Antibodies are among the most commonly used tools in the biological sciences - put to work in many experiments to identify and isolate other molecules. NCI’s Antibody Program has developed more...
December 18, 2019 | Read More